B
Barbara A. Goff
Researcher at University of Washington
Publications - 235
Citations - 12862
Barbara A. Goff is an academic researcher from University of Washington. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 61, co-authored 227 publications receiving 11859 citations. Previous affiliations of Barbara A. Goff include Georgetown University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
The essential elements of undergraduate medical education in obstetrics and gynecology: a comparison of the Association of Professors of Gynecology and Obstetrics Medical Student Educational Objectives and the National Board of Medical Examiners Subject Examination.
Maya M. Hammoud,Susan M. Cox,Barbara A. Goff,Alice R. Goepfert,Aggie Butler,David B. Swanson,Kathleen Z. Holtzman,Krista Allbee,Nadine T. Katz,Sonya S. Erickson +9 more
TL;DR: The NBME examination provides an appropriate assessment of mastery of what a medical student should learn, as represented by the APGO Medical Student Educational Objectives.
Journal Article
Recurrent ovarian granulosa cell tumor: role of combination chemotherapy with report of a long-term response to a cyclophosphamide, doxorubicin and cisplatin regimen.
TL;DR: Compared with radiotherapy, chemotherapy may yield longer survival in patients with recurrent granulosa cell tumor, but actual cure remains elusive.
Journal ArticleDOI
Updated Overall Survival Analysis in Oceans, a Randomized Phase 3 Trial of Gemcitabine (G) + Carboplatin (C) and Bevacizumab (BV) or Placebo (PL) Followed by BV or PL in Platinum-Sensitive Recurrent Epithelial Ovarian (ROC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)
TL;DR: Nguyen et al. as mentioned in this paper showed that BV in combination with GC resulted in a statistically significant and clinically meaningful improvement in PFS in patients with platinum-sensitive ROC (median PFS, 12.4 vs 8.4 months; HR = 0.484).
Journal ArticleDOI
Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer
Carol Aghajanian,Barbara A. Goff,Lawrence R. Nycum,Yulei Wang,Amreen Husain,Stephanie V. Blank +5 more
Journal ArticleDOI
Re-Engineering Academic Departments of Obstetrics and Gynecology to Operate in a Pandemic World and Beyond - A Joint AGOS/CUCOG Statement.
Ronald D. Alvarez,Barbara A. Goff,David Chelmow,Todd R. Griffin,Errol R. Norwitz,John O. De Lancey +5 more
TL;DR: This “Call to Action” paper from leaders of AGOS and CUCOG provides a framework to help leaders of Departments of Obstetrics and Gynecology re-imagine and re-engineer their operations in light of the current COVID-19 crisis and future pandemics.